Clinical Trial Update: Antibiotic De-escalation in Onco-hematology Patients for Sepsis or Septic Shock [Phase 3]

View source ↗

Summary

Phase 3 trial assessing de-escalation of antibiotic therapy in cancer patients with sepsis or septic shock has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Hematologic Malignancy
• Sepsis
• Septic Shock

Snippet

Sponsor: Institut Paoli-Calmettes | Conditions: Critical Care, Cancer | Phase 3 | Status: COMPLETED